Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib improved arthritis and partially improved hair loss in a lupus patient without side effects.

Intramuscular triamcinolone acetonide is an effective treatment for severe alopecia areata, especially in males.

Isotretinoin has many serious side effects, including some new ones, needing better safety measures and updated labels.

Upadacitinib may help treat difficult cases of systemic lupus erythematosus.

Ritlecitinib is generally safe for long-term use, with mostly mild side effects.

Isotretinoin may cause temporary, reversible facial hair growth in some women.

Tofacitinib helped a person with total body hair loss grow hair again without bad side effects.

Continued ritlecitinib treatment helps sustain hair regrowth in alopecia areata patients.

Most people on isotretinoin had chapped lips, but only a few stopped the medicine due to side effects.

Topical tofacitinib is effective and safe for treating alopecia areata.

Ritlecitinib is the first FDA-approved pill for treating significant hair loss in alopecia areata patients aged 12 and up.

Tofacitinib significantly regrows hair in severe alopecia without major side effects.

The synthetic retinoid EC23 thickens skin and promotes hair growth more effectively and with a lower dose than natural retinoids.

Isotretinoin can rarely cause hair to grow curly.

Tofacitinib effectively treats Alopecia Areata.

Continuous baricitinib is needed to keep hair regrowth in severe alopecia areata.

Applying 2% tofacitinib cream helped some children with severe hair loss grow back hair.

Baricitinib is more effective than methotrexate for severe alopecia areata.

Baricitinib effectively and safely improves hair growth in patients with severe alopecia areata.

Isotretinoin at low doses effectively treats facial papules in frontal fibrosing alopecia.

Combining excimer lamp and tofacitinib gel may help treat hair loss in children.

Tretinoin boosts minoxidil's effect on hair loss by increasing enzyme activity.

Upadacitinib effectively treated severe atopic dermatitis, vitiligo, and alopecia areata in one patient.

Systemic retinoids do not increase COVID-19 risk or severity.

Tofacitinib successfully treated hair loss in a Crohn's disease patient who previously used adalimumab.

Oral Acitretin effectively resolved symptoms in a child with Netherton syndrome.

Ritlecitinib effectively treats severe Alopecia Areata by reducing harmful immune activity in the skin.

A new mix of anthralin and calcipotriene might help treat severe hair loss.

Switching to ritlecitinib improves hair regrowth and well-being in severe alopecia areata patients.

Oral isotretinoin and cyproterone compound are equally effective for treating acne in women with cutaneous hyperandrogenism.